Quick Answer
PANACEA LIFE SCIENCES HOLDINGS, INC. reported Total Revenue of $2.38 million for fiscal year 2023.
PANACEA LIFE SCIENCES HOLDINGS, INC. — Key Financials by Year
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Total Revenue | $2.38M +46.6% |
$1.63M -21.0% |
$2.06M -77.2% |
$9.02M +2508.7% |
$345.7K | $0.00 |
| Revenue (ASC 606) | $2.38M +46.6% |
$1.63M -21.0% |
$2.06M | — | — | — |
| Net Income | -$8.02M +12.3% |
-$9.14M -91.2% |
-$4.78M +8.6% |
-$5.23M +47.8% |
-$10.02M -131.0% |
-$4.34M -12.3% |
| Diluted EPS | -$0.48 +22.6% |
-$0.62 | — | — | — | — |
| Total Assets | $17.98M -7.7% |
$19.49M -18.1% |
$23.78M +252.2% |
$6.75M -29.6% |
$9.59M +67016.3% |
$14.3K -91.7% |
| Cash and Equivalents | $100.9K +1351.9% |
$7.0K -64.8% |
$19.8K -76.6% |
$84.4K +358.5% |
$18.4K +839.0% |
$2.0K -98.8% |
| Stockholders Equity | -$8.29M -286.6% |
-$2.14M -130.2% |
$7.10M +294.0% |
$1.80M -75.9% |
$7.48M +318.3% |
-$3.42M -54.6% |
| R&D Expense | — | — | — | $0.00 -100.0% |
$22.1K -92.6% |
$300.0K -15.7% |
| Operating Income | -$5.55M +1.9% |
-$5.65M +4.8% |
-$5.94M -12.9% |
-$5.26M +50.7% |
-$10.67M -338.1% |
-$2.44M +22.0% |
| Gross Profit | $1.12M +183.0% |
$396.5K -26.7% |
$540.6K -72.9% |
$2.00M +217.5% |
-$1.70M | $0.00 |
| Shares Outstanding | 17.65M +17.9% |
14.97M +6.3% |
14.07M -16.8% |
16.92M -61.4% |
43.82M +603.0% |
6.23M +42.2% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | March 31, 2024 | $1.06M | +55.9% | +203.7% |
| Revenue (ASC 606) | March 31, 2024 | $1.06M | +55.9% | +203.7% |
| Net Income | March 31, 2024 | -$1.45M | +19.3% | +32.8% |
| Diluted EPS | March 31, 2024 | -$0.09 | +25.0% | +30.8% |
| Total Assets | March 31, 2024 | $17.41M | -6.2% | -3.2% |
| Cash and Equivalents | March 31, 2024 | $107.6K | +47.0% | +6.7% |
| Stockholders Equity | March 31, 2024 | -$9.62M | -153.2% | -16.1% |
| R&D Expense | September 30, 2020 | $0.00 | -100.0% | — |
| Operating Income | March 31, 2024 | -$1.06M | +18.0% | +25.2% |
| Gross Profit | March 31, 2024 | $666.2K | +195.3% | +354.4% |
| Shares Outstanding | March 31, 2024 | 18.31M | +18.1% | +3.8% |
- PANACEA LIFE SCIENCES HOLDINGS, INC. reported Total Revenue of $2.38 million for fiscal year 2023.
- PANACEA LIFE SCIENCES HOLDINGS, INC. showed an increase of +46.6% in Total Revenue compared to the prior fiscal year.
- PANACEA LIFE SCIENCES HOLDINGS, INC. reported Revenue (ASC 606) of $2.38 million for fiscal year 2023.
- PANACEA LIFE SCIENCES HOLDINGS, INC. showed an increase of +46.6% in Revenue (ASC 606) compared to the prior fiscal year.
- PANACEA LIFE SCIENCES HOLDINGS, INC. reported Net Income of -$8.02 million for fiscal year 2023.
- PANACEA LIFE SCIENCES HOLDINGS, INC. showed an increase of +12.3% in Net Income compared to the prior fiscal year.
- PANACEA LIFE SCIENCES HOLDINGS, INC. reported Diluted EPS of $0.48 per share (loss) for fiscal year 2023.
- PANACEA LIFE SCIENCES HOLDINGS, INC. showed an increase of +22.6% in Diluted EPS compared to the prior fiscal year.
- PANACEA LIFE SCIENCES HOLDINGS, INC. reported Total Assets of $17.98 million for fiscal year 2023.
- PANACEA LIFE SCIENCES HOLDINGS, INC. showed a decrease of -7.7% in Total Assets compared to the prior fiscal year.
- PANACEA LIFE SCIENCES HOLDINGS, INC. reported Cash and Equivalents of $100.9 thousand for fiscal year 2023.
- PANACEA LIFE SCIENCES HOLDINGS, INC. showed an increase of +1351.9% in Cash and Equivalents compared to the prior fiscal year.
- PANACEA LIFE SCIENCES HOLDINGS, INC. reported Stockholders Equity of -$8.29 million for fiscal year 2023.
- PANACEA LIFE SCIENCES HOLDINGS, INC. showed a decrease of -286.6% in Stockholders Equity compared to the prior fiscal year.
- PANACEA LIFE SCIENCES HOLDINGS, INC. reported R&D Expense of $0.00 for fiscal year 2020.
- PANACEA LIFE SCIENCES HOLDINGS, INC. showed a decrease of -100.0% in R&D Expense compared to the prior fiscal year.
- PANACEA LIFE SCIENCES HOLDINGS, INC. reported Operating Income of -$5.55 million for fiscal year 2023.
- PANACEA LIFE SCIENCES HOLDINGS, INC. showed an increase of +1.9% in Operating Income compared to the prior fiscal year.
- PANACEA LIFE SCIENCES HOLDINGS, INC. reported Gross Profit of $1.12 million for fiscal year 2023.
- PANACEA LIFE SCIENCES HOLDINGS, INC. showed an increase of +183.0% in Gross Profit compared to the prior fiscal year.
- PANACEA LIFE SCIENCES HOLDINGS, INC. reported Shares Outstanding of 17.65 million shares for fiscal year 2023.
- PANACEA LIFE SCIENCES HOLDINGS, INC. showed an increase of +17.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: